These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 34229208)
1. Immune checkpoint blockade impairs immunosuppressive mechanisms of regulatory T cells in B-cell lymphoma. Bauer V; Ahmetlić F; Hömberg N; Geishauser A; Röcken M; Mocikat R Transl Oncol; 2021 Sep; 14(9):101170. PubMed ID: 34229208 [TBL] [Abstract][Full Text] [Related]
2. The role of dendritic cells for therapy of B-cell lymphoma with immune checkpoint inhibitors. Scheuerpflug A; Ahmetlić F; Bauer V; Riedel T; Röcken M; Mocikat R Cancer Immunol Immunother; 2021 May; 70(5):1343-1350. PubMed ID: 33141285 [TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant immune checkpoint blockade triggers persistent and systemic T Blomberg OS; Kos K; Spagnuolo L; Isaeva OI; Garner H; Wellenstein MD; Bakker N; Duits DEM; Kersten K; Klarenbeek S; Hau CS; Kaldenbach D; Raeven EAM; Vrijland K; Kok M; de Visser KE Oncoimmunology; 2023; 12(1):2201147. PubMed ID: 37089449 [TBL] [Abstract][Full Text] [Related]
4. Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer. Revenko A; Carnevalli LS; Sinclair C; Johnson B; Peter A; Taylor M; Hettrick L; Chapman M; Klein S; Solanki A; Gattis D; Watt A; Hughes AM; Magiera L; Kar G; Ireland L; Mele DA; Sah V; Singh M; Walton J; Mairesse M; King M; Edbrooke M; Lyne P; Barry ST; Fawell S; Goldberg FW; MacLeod AR J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35387780 [TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Tay C; Tanaka A; Sakaguchi S Cancer Cell; 2023 Mar; 41(3):450-465. PubMed ID: 36917950 [TBL] [Abstract][Full Text] [Related]
6. Strong impact of CD4+ Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection. Abel S; Lückheide N; Westendorf AM; Geffers R; Roers A; Müller W; Sparwasser T; Matuschewski K; Buer J; Hansen W J Immunol; 2012 Jun; 188(11):5467-77. PubMed ID: 22544931 [TBL] [Abstract][Full Text] [Related]
7. Regulatory T Cells in an Endogenous Mouse Lymphoma Recognize Specific Antigen Peptides and Contribute to Immune Escape. Ahmetlić F; Riedel T; Hömberg N; Bauer V; Trautwein N; Geishauser A; Sparwasser T; Stevanović S; Röcken M; Mocikat R Cancer Immunol Res; 2019 Apr; 7(4):600-608. PubMed ID: 30894379 [TBL] [Abstract][Full Text] [Related]
8. Cellular immune responses towards regulatory cells. Larsen SK Dan Med J; 2016 Jan; 63(1):B5188. PubMed ID: 26726907 [TBL] [Abstract][Full Text] [Related]
9. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression. Zhang Y; Yao YM; Huang LF; Dong N; Yu Y; Sheng ZY J Interferon Cytokine Res; 2011 Feb; 31(2):249-57. PubMed ID: 21087077 [TBL] [Abstract][Full Text] [Related]
11. Providence of the CD25 Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956 [TBL] [Abstract][Full Text] [Related]
13. Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis. Kumar P; Saini S; Prabhakar BS Semin Cancer Biol; 2020 Aug; 64():29-35. PubMed ID: 30716481 [TBL] [Abstract][Full Text] [Related]
14. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells. Alissafi T; Hatzioannou A; Legaki AI; Varveri A; Verginis P J Autoimmun; 2019 Nov; 104():102310. PubMed ID: 31421963 [TBL] [Abstract][Full Text] [Related]
15. Roles of regulatory T cells in cancer immunity. Takeuchi Y; Nishikawa H Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722 [TBL] [Abstract][Full Text] [Related]
17. FoxP3 Saleh R; Elkord E Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 Producing Regulatory B Cells Transformed CD4 Tarique M; Naz H; Kurra SV; Saini C; Naqvi RA; Rai R; Suhail M; Khanna N; Rao DN; Sharma A Front Immunol; 2018; 9():1636. PubMed ID: 30083152 [TBL] [Abstract][Full Text] [Related]
19. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4 Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845 [TBL] [Abstract][Full Text] [Related]
20. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice. Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]